drugset / Trial / NCT02271399
Comparative Study of Prophylactic Agent for Venous Thromboembolism After Total Knee Arthroplasty
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to compare the efficacy of two prophylactic agent(aspirin 300mg/day and rivaroxaban 10mg/day) for venous thromboembolism after total knee arthroplasty.
Timeline
- Start
- 2014-10
- Primary completion
- 2016-01
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Aspirin | Small molecule | 300 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 10 mg | Oral |